VANGUARD GROUP INC 13D and 13G filings for Karuna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:08 pm Purchase |
2023-12-29 | 13G | Karuna Therapeutics, Inc. KRTX |
VANGUARD GROUP INC | 3,224,786 8.550% |
471,243 (+17.11%) |
Filing |
| 2023-02-09 11:25 am Purchase |
2022-12-30 | 13G | Karuna Therapeutics, Inc. KRTX |
VANGUARD GROUP INC | 2,753,543 8.010% |
669,207 (+32.11%) |
Filing |
| 2022-02-10 08:22 am Purchase |
2021-12-31 | 13G | Karuna Therapeutics, Inc. KRTX |
VANGUARD GROUP INC | 2,084,336 7.040% |
2,084,336 (New Position) |
Filing |